Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 70.87M | 67.93M | 65.02M | 63.46M | 61.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.87M | 67.93M | 65.02M | 63.46M | 61.91M |
| Cost of Revenue | 11.78M | 11.25M | 10.72M | 11.23M | 11.74M |
| Gross Profit | 59.09M | 56.68M | 54.30M | 52.23M | 50.18M |
| SG&A Expenses | 40.05M | 37.90M | 35.77M | 36.32M | 36.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -709.10K | -911.80K | -1.11M | -1.34M | -1.57M |
| Total Operating Expenses | 57.82M | 54.44M | 51.10M | 51.34M | 51.58M |
| Operating Income | 13.05M | 13.48M | 13.92M | 12.13M | 10.33M |
| Income Before Tax | 11.67M | 12.49M | 13.31M | 11.50M | 9.69M |
| Income Tax Expenses | 1.08M | 869.50K | 663.80K | 652.40K | 641.20K |
| Earnings from Continuing Operations | 10.59 | 11.62 | 12.64 | 10.85 | 9.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.59M | 11.62M | 12.64M | 10.85M | 9.05M |
| EBIT | 13.05M | 13.48M | 13.92M | 12.13M | 10.33M |
| EBITDA | 14.64M | 15.23M | 15.81M | 13.82M | 11.82M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 24.56B | 24.81B | 25.06B | 25.26B | 25.46B |
| Average Diluted Shares Outstanding | 24.56B | 24.81B | 25.06B | 25.26B | 25.46B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |